Bio-Rad Laboratories, Inc. (BIO.B) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Bio-Rad Laboratories, Inc. (BIO.B) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $8.48B, listed on NYSE, employing roughly 7,700 people, carrying a beta of 1.06 to the broader market. Bio-Rad Laboratories, Inc. Led by Norman D. Schwartz, public since 1999-09-21.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for BIO.B as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →